10/27/2017,作者Gareth Macdonald

Emergent Biosciences向ABEC购买一台4,000L一次性生物反应器。



ABEC 4000升单次使用生物反应器扩大了Emergent BioSolutions的制造产能

Bethlehem, PA, USA, October 24, 2017- ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that Emergent BioSolutions will equip their Baltimore, Maryland bulk manufacturing facility (Bayview), designated a Center for Innovation in Advanced Development and Manufacturing (CIADM), with an ABEC 4,000L CSR bioreactor. The system will be custom designed to Emergent’s process needs, operational requirements, and facility constraints, and will greatly expand cell culture capacity at the Bayview site.